Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration

Family Practice

Volumn 32, Issue 1, 2015, Pages 27-34

  Franch Nadal, Josep ^a,b   Roura Olmeda, Pilar ^c   Benito Badorrey, Belén ^a   Rodriguez Poncelas, Antonio ^d,e   Coll de Tuero, Gabriel ^d,e,f   Mata Cases, Manel ^b,g  

^a Primary Health Care Center Raval Sud   (Spain)

^b Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^c Health Center Badia del Valles ICS GROIMAP USR MN IDIAP Jordi Gol   (Spain)

^d PCC Anglés   (Spain)

^e Health Care Institute   (Spain)

^f UNIVERSITY OF GIRONA   (Spain)

^g La Mina Primary Health Care Centre   (Spain)

Author keywords

Cardiovascular risk factors; Control; Disease duration; T2DM

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY HEALTH CARE; SECONDARY PREVENTION; SMOKING; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERCHOLESTEROLEMIA; HYPERTENSION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84922437815     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmu048     Document Type: Article

References (27)

1. Soriguer F, Goday A, Bosch-Comas A et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012; 55: 88-93.
2. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378: 169-81
3. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care 2013: 36 (suppl 1): S11-66.
4. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-91
5. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW; Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 2004; 27: 704-8
6. Seshasai SR, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. Emerging Risk Factors Collaboration. N Engl J Med 2011; 364: 829-41
7. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011; 171: 404-10
8. Stevens RJ, Kothari V, Adler AI, Stratton IM; United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-9
9. Kengne AP, Patel A, Marre M et al.; ADVANCE Collaborative Group. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 2011; 18: 393-8
10. Shah AS, Dolan LM, Kimball TR et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 3740-5
11. Meyer MF, Lieps D, Schatz H, Klein HH, Pfohl M. Influence of the duration of type 2 diabetes on early functional and morphological markers of atherosclerosis compared to the impact of coexisting classic cardiovascular risk factors. Exp Clin Endocrinol Diabetes 2008; 116: 298-304
12. Cano JF, Baena-Diez JM, Franch J et al.; REGICOR and GEDAPS Investigators. Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe. Diabetes Care 2010; 33: 2004-9
13. Hu FB, Stampfer MJ, Solomon CG et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001; 161: 1717-23
14. UK Prospective Diabetes Study (UKPDS) Group; Holman RR, Sanjoy PK, Bethel MA, Matthews DR, Neil MA. 10-Year Follow-up of intensive glucosecontrol in Type 2 diabetes. N Engl J Med 2008; 359: 1577-89
15. Morato Griera J, Franch Nadal J, Carrillo Muñoz R et al. Chronology of complications from diabetes in adults. The Raval Sud study. An Med Interna 1995; 12: 431-7
16. Orozco-Beltrán D, Gil-Guillen VF, Quirce F et al.; Collaborative Diabetes Study Investigators. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain. Int J Clin Pract 2007; 61: 909-15
17. Franch Nadal J, Artola Menéndez S, Diez Espino J, Mata Cases M; en representación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud. The evolution of quality care indicators of patients with type 2 diabetes in the Spanish primary care (1996-2007). The RedGEDAPS quality of care program. Med Clin (Barc) 2010; 135: 600-7
18. Mata-Cases M, Roura-Olmeda P, Berengué-Iglesias M et al.; Diabetes Study Group in Primary Health Care (GEDAPS: Grup d'Estudi de la Diabetis a l'Atenció Primària de Salut, Catalonian Society of Family and Community Medicine). Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain. Int J Clin Pract 2012; 66: 289-98
19. Vinagre I, Mata-Cases M, Hermosilla E et al. Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 2012; 35: 774-9
20. a edición. Madrid: Elsevier.
21. Programa de mejora de la calidad redGedaps. Evaluación de la atención a la diabetes en atención primaria. http://www.redgdps.org/index.php?idregistro=259 (accessed on 31 March 2014).
22. Mata-Cases M, Mauricio D, Vinagre I et al. Treatment of Hyperglycaemia in Type 2 Diabetic Patients in a Primary Care Population Database in a Mediterranean Area (Catalonia, Spain). J Diabetes Metab. 2014; 5: 338.
23. Conthe P, Mata M, Orozco D et al. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain. Diabetes Res Clin Pract 2011; 91: 108-14
24. Mata-Cases M, Benito-Badorrey B, Roura-Olmeda P et al.; GEDAPS (Primary Care Group for the study of Diabetes) of the Catalonian Society of Family and Community Medicine. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care. Curr Med Res Opin 2013; 29: 1495-502
25. Liebl A, Mata M, Eschwège E; CODE-2 Advisory Board. Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 2002; 45: S23-8.
26. De la Calle H, Costa A, Diez-Espino J, Franch J, Goday A. Evaluacion del cumplimiento de los objetivos de control metabolico de la diabetes mellitus tipo 2. Estudio TranSTAR. Med Clin (Barc) 2003; 120: 446-50
27. Inzucchi SE, Bergenstal RM, Buse JB et al.; . Management of hyperglycemia in type 2 diabetes: a patientcentered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-79